About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Lupin Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Sanofi Cons. Health
5285.7
90.45
1.74
86.84
60.87
48
7.04
1.04
118.26
Alkem Laboratories
5499.7
52.85
0.97
185.84
29.59
2780
-13.49
0.82
1030.68
Caplin Point Lab
2273.1
29.05
1.29
46.42
48.97
5132
15.97
0.26
221.22
Procter&Gamble Healt
6283.65
27.4
0.44
181.09
34.7
558
21.86
1.99
320.52
Alembic Pharma
972.25
26.45
2.8
21.9
44.4
8848
-17.77
1.13
264.3
Divi's Lab
6052.4
25.85
0.43
88
68.78
7313
10.46
0.5
562.08
Concord Biotech
1656.65
21.75
1.33
34.15
48.51
1727
-20.57
0.65
173.27
Acutaas Chemicals
1459.75
15.2
1.05
23.27
62.74
23641
89.65
0.05
160.19
Aarti Pharmalabs
939.8
13.25
1.43
28.84
32.58
33725
39.01
0.53
203.25
Jagsonpal Pharma
250.15
9.25
3.84
9.13
27.4
39102
52.72
1
64.43
Akums Drugs & Pharma
470.7
8.7
1.88
10.42
45.18
17341
-47.06
0
150.57
Themis Medicare
131.36
8.64
7.04
-0.96
0
318820
-52.95
0.38
34.8
Sai Life Sciences
881.05
8.4
0.96
8.28
106.36
20223
0
103.76
Haleos Labs
1204
7.95
0.66
66.38
18.14
367
-23.8
0.12
582.9
Everest Organics
429
7.8
1.85
6.38
67.21
3270
215.33
0
57.3
Amrutanjan Healthcar
761.7
6.35
0.84
18.86
40.38
2098
-3.04
0.6
112.83
Bafna Pharma
124
5.9
5
3.49
35.49
29175
52.28
0
35.85
BDH Inds
403.8
5.85
1.47
16.55
24.39
17477
14.44
1.11
117.14
Advanced Enzyme
344.35
5.5
1.62
9.77
35.23
30670
-37.37
1.51
55.81
Godavari Drugs
87.29
5.01
6.09
5.03
17.35
9584
-34.37
0
51.74
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.